GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Price-to-Tangible-Book

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Price-to-Tangible-Book : 2.98 (As of May. 15, 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Price-to-Tangible-Book?

As of today (2024-05-15), China Resources Double-Crane Pharmaceutical Co's share price is ¥23.38. China Resources Double-Crane Pharmaceutical Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ¥7.84. Hence, China Resources Double-Crane Pharmaceutical Co's Price to Tangible Book Ratio of today is 2.98.

The historical rank and industry rank for China Resources Double-Crane Pharmaceutical Co's Price-to-Tangible-Book or its related term are showing as below:

SHSE:600062' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.69   Med: 2.51   Max: 4.03
Current: 2.98

During the past 13 years, China Resources Double-Crane Pharmaceutical Co's highest Price to Tangible Book Ratio was 4.03. The lowest was 1.69. And the median was 2.51.

SHSE:600062's Price-to-Tangible-Book is ranked worse than
59.17% of 867 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs SHSE:600062: 2.98

A closely related ratio is called PB Ratio. As of today, China Resources Double-Crane Pharmaceutical Co's share price is ¥23.38. China Resources Double-Crane Pharmaceutical Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was ¥11.08. Hence, China Resources Double-Crane Pharmaceutical Co's P/B Ratio of today is 2.11.


China Resources Double-Crane Pharmaceutical Co Price-to-Tangible-Book Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Price-to-Tangible-Book Chart

China Resources Double-Crane Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.22 1.83 1.93 2.59 2.51

China Resources Double-Crane Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.50 2.50 2.39 2.51 2.64

Competitive Comparison of China Resources Double-Crane Pharmaceutical Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Double-Crane Pharmaceutical Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Double-Crane Pharmaceutical Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Double-Crane Pharmaceutical Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where China Resources Double-Crane Pharmaceutical Co's Price-to-Tangible-Book falls into.



China Resources Double-Crane Pharmaceutical Co Price-to-Tangible-Book Calculation

China Resources Double-Crane Pharmaceutical Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=23.38/7.836
=2.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


China Resources Double-Crane Pharmaceutical Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines